Position in LLY
as of Jun 30, 2026
· filed Jul 7, 2026
Position Value
$21,630,522
+$4,428,984 QoQ
Shares Held
18,034
-3.6% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
2.92%
of 13F equity value
Holder Rank
#853
of 4,605 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026BDF-GESTION holds $47,173,274 across 6 Drug Manufacturers - General names. LLY ranks #1 (45.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
18,034 | $21,630,522 | |
| 2 | ABBV |
AbbVie Inc.
|
40,006 | $10,067,109 | |
| 3 | MRK |
Merck & Co., Inc.
|
42,451 | $5,454,953 | |
| 4 | JNJ |
Johnson & Johnson
|
20,620 | $5,236,861 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
21,801 | $2,754,338 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
35,222 | $2,029,491 |
All Filings in LLY
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $21,630,522 | 18,034 | Shares | Sole | 2026-07-07 | |
| 2026-03-31 | $17,201,538 | 18,702 | Shares | Sole | 2026-04-10 | |
| 2025-12-31 | $20,098,667 | 18,702 | Shares | Sole | 2026-01-09 | |
| 2025-09-30 | $15,221,087 | 19,949 | Shares | Sole | 2025-10-09 | |
| 2025-06-30 | $18,785,113 | 24,098 | Shares | Sole | 2025-07-11 | |
| 2025-03-31 | $22,071,618 | 26,724 | Shares | Sole | 2025-04-17 | |
| 2024-12-31 | $20,630,928 | 26,724 | Shares | Sole | 2025-01-23 | |
| 2024-09-30 | $26,751,844 | 30,196 | Shares | Sole | 2024-10-15 | |
| 2024-06-30 | $27,338,854 | 30,196 | Shares | Sole | 2024-07-11 | |
| No filing history on record for this holder in this stock. | ||||||